Learn about the latest news and events going on in the department. You can also follow us on X @WashUMedNeuro and LinkedIn.

Case report shows how fluoxetine (Prozac) was repurposed to treat a severe seizure disorder in two sisters under treatment at WashU Medicine

Case report shows how fluoxetine (Prozac) was repurposed to treat a severe seizure disorder in two sisters under treatment at WashU Medicine (Links to an external site)

In Frontiers in Pharmacology, Lawrence Salkoff, PhD, and colleagues report how norfluoxetine, a long-lasting metabolite of fluoxetine that may accumulate in the brain at greater concentrations than fluoxetine itself in patients treated with fluoxetine, is most likely the agent bringing relief to the patients.
Kepecs awarded NIH Director’s Pioneer Award

Kepecs awarded NIH Director’s Pioneer Award (Links to an external site)

Adam Kepecs, PhD, the Robert J. Terry Professor of Neuroscience and a professor of psychiatry at Washington University School of Medicine in St. Louis, has been selected for a National Institutes of Health (NIH) Director’s Pioneer Award, to study how the brain’s neural circuits decode signals from the immune system and orchestrate adjustments in behavior and motivation.
Now accepting applications for WashU Medicine Bold Pioneer Award!

Now accepting applications for WashU Medicine Bold Pioneer Award! (Links to an external site)

The goal of the $10,000 WashU Medicine Bold Pioneer Award is to recognize and encourage early career investigators who have demonstrated bold, pioneering research that is high-risk by virtue of being fundamentally different from standard approaches. The intent is to encourage scientific research investigators to challenge status quo approaches by developing fundamentally different methods, approaches, […]